Annual Debt To Equity:
3.56+0.17(+5.01%)Summary
- As of today, RARE annual debt to equity ratio is 3.56, with the most recent change of +0.17 (+5.01%) on December 31, 2024.
- During the last 3 years, RARE annual debt to equity has risen by +3.13 (+727.91%).
- RARE annual debt to equity is now at all-time high.
Performance
RARE Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Debt To Equity:
94.24+88.40(+1513.70%)Summary
- As of today, RARE quarterly debt to equity ratio is 94.24, with the most recent change of +88.40 (+1513.70%) on September 30, 2025.
- Over the past year, RARE quarterly debt to equity has increased by +91.61 (+3483.27%).
- RARE quarterly debt to equity is now at all-time high.
Performance
RARE Quarterly Debt To Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Debt To Equity Formula
Debt To Equity = Total Debt
Shareholders Equity
Total Debt
Shareholders Equity
Shareholders Equity
RARE Debt To Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +5.0% | +3483.3% |
| 3Y3 Years | +727.9% | +4834.0% |
| 5Y5 Years | +559.3% | +10000.0% |
RARE Debt To Equity Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +727.9% | at high | +4834.0% |
| 5Y | 5-Year | at high | +978.8% | at high | >+9999.0% |
| All-Time | All-Time | at high | >+9999.0% | at high | >+9999.0% |
RARE Debt To Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | 94.24(+1513.7%) |
| Jun 2025 | - | 5.84(-5.3%) |
| Mar 2025 | - | 6.17(+73.3%) |
| Dec 2024 | 3.56(+5.0%) | 3.56(+35.4%) |
| Sep 2024 | - | 2.63(+22.9%) |
| Jun 2024 | - | 2.14(-67.8%) |
| Mar 2024 | - | 6.65(+96.2%) |
| Dec 2023 | 3.39(+31.9%) | 3.39(-88.7%) |
| Sep 2023 | - | 30.04(+316.6%) |
| Jun 2023 | - | 7.21(+72.9%) |
| Mar 2023 | - | 4.17(+62.3%) |
| Dec 2022 | 2.57(+497.7%) | 2.57(+34.6%) |
| Sep 2022 | - | 1.91(+229.3%) |
| Jun 2022 | - | 0.58(+16.0%) |
| Mar 2022 | - | 0.50(+16.3%) |
| Dec 2021 | 0.43(+30.3%) | 0.43(+2.4%) |
| Sep 2021 | - | 0.42(+5.0%) |
| Jun 2021 | - | 0.40(+8.1%) |
| Mar 2021 | - | 0.37(+12.1%) |
| Dec 2020 | 0.33(-38.9%) | 0.33(-41.1%) |
| Sep 2020 | - | 0.56(+5.7%) |
| Jun 2020 | - | 0.53(-11.7%) |
| Mar 2020 | - | 0.60(+11.1%) |
| Dec 2019 | 0.54 | 0.54(+980.0%) |
| Sep 2019 | - | 0.05(0.0%) |
| Jun 2019 | - | 0.05(+66.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | 0.03(>+9900.0%) |
| Dec 2018 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2018 | - | 0.00(0.0%) |
| Jun 2018 | - | 0.00(0.0%) |
| Mar 2018 | - | 0.00(0.0%) |
| Dec 2017 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2017 | - | 0.00(0.0%) |
| Jun 2017 | - | 0.00(0.0%) |
| Mar 2017 | - | 0.00(0.0%) |
| Dec 2016 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2016 | - | 0.00(0.0%) |
| Jun 2016 | - | 0.00(0.0%) |
| Mar 2016 | - | 0.00(0.0%) |
| Dec 2015 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2015 | - | 0.00(0.0%) |
| Jun 2015 | - | 0.00(0.0%) |
| Mar 2015 | - | 0.00(0.0%) |
| Dec 2014 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2014 | - | 0.00(0.0%) |
| Jun 2014 | - | 0.00(0.0%) |
| Mar 2014 | - | 0.00(0.0%) |
| Dec 2013 | 0.00(0.0%) | 0.00(0.0%) |
| Sep 2013 | - | 0.00(0.0%) |
| Jun 2013 | - | 0.00(0.0%) |
| Dec 2012 | 0.00(0.0%) | 0.00 |
| Dec 2011 | 0.00 | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual debt to equity ratio?
- What is the all-time high annual debt to equity for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual debt to equity year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly debt to equity ratio?
- What is the all-time high quarterly debt to equity for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly debt to equity year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual debt to equity ratio?
The current annual debt to equity of RARE is 3.56
What is the all-time high annual debt to equity for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual debt to equity ratio is 3.56
What is Ultragenyx Pharmaceutical Inc. annual debt to equity year-on-year change?
Over the past year, RARE annual debt to equity ratio has changed by +0.17 (+5.01%)
What is Ultragenyx Pharmaceutical Inc. quarterly debt to equity ratio?
The current quarterly debt to equity of RARE is 94.24
What is the all-time high quarterly debt to equity for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly debt to equity ratio is 94.24
What is Ultragenyx Pharmaceutical Inc. quarterly debt to equity year-on-year change?
Over the past year, RARE quarterly debt to equity ratio has changed by +91.61 (+3483.27%)